Published • loading... • Updated
Is This News From Novo Nordisk a Warning for Eli Lilly Shareholders?
Summary by The Motley Fool
1 Articles
1 Articles
Is This News From Novo Nordisk a Warning for Eli Lilly Shareholders?
Key PointsEli Lilly and Novo Nordisk dominate the weight loss drug market with their injectable GLP-1 drugs.Both players recently won approval for oral formulations, offering patients a new, convenient option.10 stocks we like better than Eli Lilly › Eli Lilly (NYSE: LLY) and Novo Nordisk (NYSE: NVO) have been leaders in an area that's seen explosive demand over the past few years: the weight loss drug market. And growth is far from over. Analys…
·Alexandria, United States
Read Full ArticleCoverage Details
Total News Sources1
Leaning Left1Leaning Right0Center0Last UpdatedBias Distribution100% Left
Bias Distribution
- 100% of the sources lean Left
100% Left
L 100%
Factuality
To view factuality data please Upgrade to Premium
